
- Pharmaceutical Executive-03-01-2010
- Volume 0
- Issue 0
Palio
The faces and names behind the year's best pharmaceutical advertising.
Tough Guys
Palio
BRAND Colcrys CLIENT URL Pharma
People don't traditionally relate Earl Grey tea with the image of a rough and tumble biker. That's exactly the contrast Palio wanted physicians to see when it launched its ad campaign for URL Pharma's gout treatment Colcrys, a new brand established from a legacy drug. The drug had recently completed a battery of testing to establish a new treatment regiment that lowered the instances of side-effects. The ad visually marries the drug's well-known strength with the new refinements discovered through clinical trials. "Because there weren't established dosing guidelines as to how to administer Colcrys, no one knew what was an appropriate dose," says Palio's VP, Associate Creative Director, Neall Currie. "The leading association with Colcrys was that it worked, but it had these severe GI side effects." The biggest challenge was to change physicians' negative perceptions that might have carried over from the older treatment. The characters used in the ad have a bit of an outcast nature to them. They're tough guys—outlaws, even. Palio wanted doctors to visualize the brutish strength representative of what Colcrys was, while adding a subtle, comical twist to show what it has become.
FROM LEFT: Julie Priddle, account director, Amanda Murphy, senior copywriter, Neall Currie, VP, associate creative director, Joe Acee, group art supervisor, Eric Delnicki, group art supervisor
Articles in this issue
over 15 years ago
Pharmaceutical Executive Digital Edition - March 2010over 15 years ago
JWTover 15 years ago
Sixth Annual Press Auditover 15 years ago
Stay Ahead of the Technology Curveover 15 years ago
E-Health to Drive Drug Safetyover 15 years ago
Echo Torre Lazurover 15 years ago
The Race Is Onover 15 years ago
MicroMassover 15 years ago
Saatchi & Saatchiover 15 years ago
Moving Beyond Compliant Social MediaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





